CClinicalTrials.gg
RecruitingNCT06511856Updated Jul 22, 2024

FH ORTHO Shoulder Observatory

An observational study in Trauma and Arthropathy Shoulder, sponsored by FH ORTHO. Recruiting at 3 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-22.

Sponsored by FH ORTHO · Observational

From the registry’s dates

  • Started Sep 2022; still recruiting 4 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
500
Ages
18 Years and older
Sex
All
01

Study summary

This study is a real-life observatory designed to collect long-term clinical data on patients who have undergone shoulder joint replacement or repair following shoulder trauma.

In this type of intervention, one or more medical devices distributed by FH ORTHO SAS may be used by surgeons.

This study meets the requirement for post-market clinical follow-up (PMCF) as defined in the European Medical Device Regulation (MDR 2017/745).

It therefore involves collecting in real life, i.e. under the usual conditions of surgery and short and long-term patient follow-up, minimal clinical data that will make it possible to document the continued benefit/risk of the medical devices concerned.

This study is designed as a permanent long-term observatory, of a non-interventional nature, with the objective of having long-term follow-up data (5 to 10 years depending on the devices concerned) for a maximum number of patients included.

02

Conditions studied

  • Trauma
  • Arthropathy Shoulder

Browse trials for

03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's planned enrollment of 500 is above the median of 100 across 216 observational studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

FH ORTHO is the lead sponsor of 9 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Any patient considered for implantation or use of medical devices for shoulder arthroplasty and traumatology distributed by FH ORTHO SAS.

Inclusion criteria

  1. Any patient undergoing implantation of medical devices distributed by FH ORTHO SAS for shoulder arthroplasty and traumatology, used in accordance with their approved labelling, in one of the centres participating in the Observatory (retrospectively or prospectively)
  2. Patient is at least 18 years of age
  3. Patient agreeing to participate after having been informed orally and in writing (with written consent if required locally) In some countries, such as France, the patient will have to be socially insured to be included in the study.

Exclusion criteria

Exclusion criteria:

  1. Patient unable to participate in the study and/or complete the questionnaires 2. Refusal of patient participation

-

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • FH ORTHO shoulder patients

    Patients operated with FH ORTHO shoulder medical devices (arthroplasty and trauma)

    Device: ARROW

Interventions

  • DeviceARROW

    Patients included in the study are patients operated with one or more shoulder medical device fabricated by FH ORTHO. Medical devices of interest are CE marked and include ARROW and ARROW prosthesis, Telegraph Evolution humeral nail and STRAPFLEX strapping system.

    Also known as: ARROW II, Telegraph Evolution, STRAPFLEX

06

What researchers measure

Primary outcomes

  1. Performance of the medical devices over long term follow-up (maximum10 years)

    Functional performance measured by the Constant-Murley score

    Time frame: maximum 10 years

Secondary outcomes

  1. revision rate medical devices over long term follow-up (maximum10 years)

    Time frame: maximum 10 years

07

Study locations

3 of 3 sites recruiting
  • Clinique VIA DOMITIA
    Lunel, 34400, France
    • Omar NAJI, Dr · Contact · +33 (0) 4 67 91 18 05
    Recruiting
  • Clinique Bizet
    Paris, 75116, France
    • Philippe VALENTI, Dr · Contact · +33 (0) 184 130 454
    Recruiting
  • Clinique de l'Union
    Saint-Jean, 31243, France
    • Jean KANY, Dr · Contact · +33 (0)5.61.37.87.47
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06511856
Lead sponsor
FH ORTHO
Responsible party
Sponsor
First posted
Jul 22, 2024
Start date
Sep 8, 2022
Primary completion
Sep 8, 2032 (estimated)
Completion
Sep 8, 2035 (estimated)
Last update
Jul 22, 2024

Study contacts

Cédric FERRY
Contact
c.ferry@fhortho.com
+33 (0)6 49 63 78 29
Stéphanie LHUILLIER
Contact
s.lhuillier@fhortho.com
+33 (0)6 07 34 59 65

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion